ICON plc is a leading Clinical Research Organisation (CRO) providing comprehensive services across the entire lifecycle of drug and device development, spanning global programs and specialized sectors.

We help clients accelerate innovation by leveraging integrated technologies, managing complex clinical studies (including Cell and Gene Therapies and vaccine trials), and ensuring patient safety. ICON specializes in navigating challenges related to COVID-19, regulatory evolution, and the integration of real-world data (RWD) and digital health technologies.

We offer flexible, patient-centric solutions—from site management and remote training to decentralized trials—ensuring optimal efficiency, compliance, and success in evolving global markets.